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Objective: To examine the clinical epidemiology and treatment ﬁndings of tuberculosis
in Babol, Northern Iran.
Methods: This cross-sectional study was carried out on medical records of tuberculosis
registry pertaining to health center of Babol City, Mazandaran, Iran. The investigated vari-
ables included demographic characteristics and some clinical patterns of patients. To present
the ﬁndings, the descriptive statistics such as mean (and SD) and frequency (%) was used.
Analytical statistics was applied by using Chi-square test and independent samples t-test.
Results: The average age of 200 patients infected with tuberculosis was 47.51 years
(SD = 21.36), and 58.5% of the cases were male. In both genders, the highest number of
tuberculosis patient was found in 18–38 age group. During the 5-year study period, 95%
of the patients received treatment protocol 1 (including new cases with positive smear,
negative smear, extra-pulmonary) and in the end of treatment given to patients, 90.5%
were improved or treatment period completed. The most important clinical symptoms for
referring the patients to the therapeutic centers were cough (75.1%) and fever (60.9%).
Conclusions: Education and giving information to general population about the most
important clinical symptoms of tuberculosis such as fever and cough might be effective in
early detection and prevention of Mycobacterium tuberculosis. Then treatment might be
effective in decreasing the burden of the disease.1. Introduction
Infection with Mycobacterium tuberculosis (M. tuberculosis)
causes tuberculosis (TB) in mammals such as humans[1]. This
infection leads to substantial economic losses[2]. It is one ofthe main public health problems[3,4] which afﬂicted about one
third of the world population[3]. This pathogenic agent is
usually transmitted from those infected in the pulmonary
forms to the others[5] and it is diagnosed by sputum samples
test[6]. Prevalence of TB is associated with some epidemiologic
factors like HIV/AIDS epidemics, low social and economic
level, over-population and malnutrition[7,8]. According to
several studies, the main identiﬁed risk factors of TB are age,
gender, having positive or negative smear, direct observed
treatment of cases by healthcare workers, the co-morbidity
with HIV infection and diabetes mellitus[3,9–11].
From the global burden perspective, TB is in the tenth place and
it is anticipated that this disease will stay in that place or even come
to the seventh place until 2020. The main priorities in TB controlarticle under the CC BY-NC-ND license (http://
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decreasing TB associated deaths to one person in a million by the
year 2050[12]. Technology development in developed countries,
population rise, increased medical costs and the critical role of
education in treatment of patients together with a good
relationship with patients will lead to better treatment results[13,14].
In 2013, the prevalence of TB has been 21 people per one
hundred thousand people in Iran[15–23]. The prevalence of TB in
marginal parts of Iran like provinces of Sistan-va-Baluchistan,
Khorasan, Mazandaran, Guilan, Western Azerbaijan, Eastern
Azerbaijan, Ardabil, Kurdistan, Khuzestan and south costal
parts is high and on the contrary in the central parts of the
country it is low[24]. Provinces of Golestan and Sistan-va-
Baluchistan have the highest incidence and prevalence of TB
in Iran. The age group of 60–80 years old has the highest per-
centage of TB patients with the rate of 90.1%[16].
In order to control every disease, other than its surveillance,
doing some cross sectional studies is needed to ﬁnd out its
epidemiologic pattern. Therefore, this study aimed to describe the
clinical epidemiology of TB in Babol City during a 5-year period
so that we will have an overview of TB pattern and provide some
effective recommendations to improve the situation.Table 1
The details of demographic characteristics of TB patients referred to
Babol Health Centre (2009–2013).
Variables Groups Frequency (%)
Gender Male 117 (58.5)
Female 83 (41.5)
Living place Urban 103 (51.5)
Rural 97 (48.5)
Marital status Married 160 (80.0)
Single 35 (17.5)
Others 5 (2.5)
Education Illiterate or primary school 105 (52.5)
Under high school 50 (25.0)
High school and academic 45 (22.5)
Job Farmer 30 (15.0)
Jobless 21 (10.5)2. Materials and methods
2.1. Study design and sampling
This was a cross sectional study which was performed in
Babol Health Centre from April 2009 to March 2013 using
census sampling method. The study site, Babol, is located in the
northern part of Iran on the costal line of Caspian Sea with
humid climate.
In this study, data were collected from TB registry and ac-
cording to patients' proﬁle in the health centre. Patients' infor-
mation has been collected and documented by experienced
personnel of Babol Health Centre and under supervision of a
physician who was the coordinator of TB control program. The
study populations were all TB patients who were identiﬁed ac-
cording to the ﬂowchart approved by the Ministry of Health
during the study period. The inclusion criteria were being a
registered TB patient, being either Iranian or non-Iranian and
having a complete medical proﬁle and exclusion criteria were
wrong TB diagnosis, uncompleted information in medical proﬁle
or migration from the city. Totally, 201 patients were registered
during the 5 years study period and one patient was excluded due
to incomplete proﬁle. For the remaining 200 patients, question-
naires were ﬁled according to the recorded information.House wife 58 (29.0)
Others 91 (45.5)
Table 2
The age group and gender of TB patients referred to Babol Health Centre
(2009–2013).
Age groups Frequency (%) P
Male Female
< 7 1 (0.9) 4 (4.8) 0.005
7–18 1 (0.9) 6 (7.2)
18–38 50 (42.7) 28 (33.7)
38–60 22 (18.8) 25 (30.1)
> 60 43 (36.8) 20 (24.1)2.2. Study variables
The investigated variables included age, gender, education
level, job, marital status, the living place and some clinical
characteristics of patients like successful treatment (cured and
completed treatment course) and unsuccessful treatment
(incomplete treatment, treatment failure, death and migration),
history of contact with a TB patient, apparent clinical symptoms
at the time of coming to the health centre, type of treatment
regimen, history of having TB risk factors, history of hospital-
ization, and the name of TB diagnosing centre.
The collected data was analysed by SPSS statistical software
version 19. Descriptive characteristics of patients were presentedby mean (SD) for normal quantitative variables and median and
interquartile range for non-normal ones. Qualitative variables
were also presented by frequency (%). To investigate the sig-
niﬁcance of associations between qualitative variables, we used
Chi-square test and in case of limitation in the frequency of
observations, we used Fishers exact test. We also used inde-
pendent samples t-test to compare the means of qualitative
variables with the assumption of equal variances. P value of less
than 0.05 was considered as the signiﬁcance level.
2.3. Ethic statement
The study protocol was performed according to the Helsinki
declaration and approved by the institutional review board
which is the Ethics Committee of Babol University of Medical
Sciences. The TB patient's information was kept conﬁdentially
and informed written consent was obtained from all patients.
3. Results
Totally 200 TB patients were recruited in this study from
2009 to 2013. The mean age of patients was 47.51 years old
(SD = 21.36) with the age range of 1–91 years old. The mean
age of male and female was 50.04 (SD = 20.42) and 43.93
(SD = 22.25) years, respectively. There was a statistically sig-
niﬁcant association between patients' mean age and sex
(P = 0.04). A total of 103 patients (51.5%) were living in urban
areas. The details of some demographic characteristics of TB
patients referred to Babol Health Center are summarized in
Table 1. The highest rate of TB patients in both sexes was in age
group of 18–38 years, followed by age group of > 60 years in
male and 38–60 years in female (Table 2).
Figure 1. Comparison of treatment results among two groups of TB pa-
tients referred to Babol Health Centre (2009–2013).
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diagnosed to have AIDS. From the perspective of risk factors
of AIDS in TB patients, 37 patients were tested for HIV
including 9 prisoners (23.7%), 1 prisoner's spouse (2.6%), 5
with the history of drug injection. In addition, 22 (57.9%)
patients were tested in the national screening program. A sta-
tistically signiﬁcant association was observed between job and
having AIDS (P = 0.001). There was also a signiﬁcant asso-
ciation between age and AIDS risk factors (P = 0.001). The
places of diagnosing these patients were as follows: 140 (70%)
in government hospitals, 23 (11.5%) clinics, 21 (10.5%) health
centres, 12 (6%) self-reporting, 3 (1.5%) private hospitals and 1
person (0.5%) was diagnosed in prison. In addition, 46 patients
(23.5%) reported the history of contact with a TB patient. The
TB contact history of patients according to the time is pre-
sented in Table 3.Table 3
History of contact with a TB patient.
Frequency of history of contact in years Frequency (%)
< 2 15 (32.6)
2–5 11 (23.9)
> 5 20 (43.5)
Figure 2. Frequency of apparent clinical symptoms leading to referral to
Babol Health Centre (2009–2013).
C: Cough; F: Fever; S: Sputum; P: Perspiration; H: Haemoptysis; W:
Weight loss.In this study, according to the national guideline, only for 6
qualiﬁed patients the antibiogram test was done, and of them, 5
patients (2.5%) showed sensitivity to the drug and 1 patient
(0.5%) showed no sensitivity. Table 4 shows the distribution of
therapeutic services among TB patients according to the treat-
ment protocol. Adverse effect of drugs was reported in 15
(7.5%) patients. According to the treatment results, the majority
of patients who had died due to TB or other causes and also
cases of treatment failure and treatment cut, were in treatment
Group 2 (Figure 1).Table 4




































H: Isoniazid; R: Rifampin; Z: Pyrazinamide; E: Ethambutol; S:
Streptomycin.The early symptoms of TB in the studied population included
cough [131 (66.2%)], fever [19 (9.6%)], asthma [7 (3.5%)] and
neck oedema [6 (3%)]. In addition, cough and fever were the
main causes of referring to the health centre. The frequency of
other symptoms is shown in Figure 2. In the studied population,
103 patients (51.5%) had the history of hospitalization before
their TB diagnosis. In patients with the history of TB related riskfactors, 29 (14.5%) had diabetes, 8 (4%) drug injection, 4 (2%)
cancer and 10 (5%) had other diseases.
4. Discussion
According to the study ﬁndings, age group of 18–38 years
old had the highest number of TB patients in both genders,
followed by age group of > 60 years in male and 38–60 years
age group in female. A statistically signiﬁcant association was
observed between variables of age and gender (Table 2). In a
study of Khazaei et al. in Hamedan Province, Iran, age group of
> 60 years old had the highest number of TB patients[17]. In a
study conducted by Gholami et al. in Urmia City, Iran, most
of TB patients were in age group of 31–40 years old[18]. In
most of the studies conducted in Iran, the highest number of
TB patients has been in > 60 years old age group[16,19]. It
seems that the high number of TB patients in 18–40 years old
age group is due to the higher population of this group in
comparison with other age groups, or maybe it is due to some
issues like high rate of addiction in the province and referring
the patients from all existing camps in the province to the
health centres. In age group of > 60 years old, weakness of
immune system and having contact with children and other
family members increase the risk of opportunistic infections
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prevalent among them.
In this study, men constituted a high proportion of TB pa-
tients. In a study by Babamahmoodi et al. conducted in Northern
Iran, the TB incidence rate was higher in men as well[20].
Generally, according to the studies conducted in Iran, the
number of TB patients in men is more than women[21,22]. It
seems to be due to the genetic factors, nutrition, frequency of
men out of home and job related factors.
Results of this study show that most of the TB patients have
been diagnosed in governmental hospitals, clinics and health
centres. In study by Hassanzadeh et al., governmental hospitals,
clinics and private hospital had the highest report of diagnosis[4].
In another study conducted by Masjedi et al. in Tehran, the
percentage of TB diagnosis by private sector was 87.3%[23].
According to the ﬁndings of the mentioned study, there is a
weak relationship and coordination between governmental
systems and private sector[23]. Having the highest reports of
TB diagnosis from governmental hospitals shows that TB
patients have passed from the ﬁrst level of health care services
without being diagnosed and for diagnosis or hospitalization
they have been referred to the hospitals and in this process,
the time between onset of symptoms and diagnosis will be
longer. Therefore it is recommended that health houses and
health centres as the ﬁrst levels of providing health services to
people do require actions for early diagnosis of patients.
In this study, a statistically signiﬁcant association was
observed between job and having AIDS and also between age
and AIDS risk factors (P = 0.001). In study of Khazaei et al., the
highest number of TB and HIV cases which were mostly found
in male was observed in 31–60 years old age group (90.7%) with
the mean age of 36.2 years old[17].
According to the treatment results, totally 90.5% of TB patients
were in the cured and completed treatment course group (Category
of treatment 1) (Figure 1). Another study in the Babol City re-
ported that 90% of TB cases had completed the treatment course
and improved[25]. In Golestan Province, Iran at the beginning of 5th
month of treatment, the rate of treatment failure in direct observed
treatment strategy (DOTS) group was 1.7% while the rate of
treatment failure in control group was 7.3%. Therefore a
signiﬁcant correlation between treatment strategy and treatment
failure rate was observed[26]. In a study conducted to compare the
efﬁcacy of family based DOTS with professional-family mix
DOTS in Tabriz City, in 2 and 4 months periods, professional-
family mix DOTS had better efﬁcacy[27]. Studies conducted all
around the world have shown that implementation of DOTS
may promote treatment success up to 90%–95%[28,29]. In a study
conducted in Iranian capital city (Tehran), it was estimated that
the mean costs for a TB patient include 28467737 Rials (2588
US Dollars) for direct medical costs, 1011360 Rials (92 US
Dollars) for indirect medical costs and 5533020 Rials (503 US
Dollars) for other indirect costs. Since high costs of TB
treatment are usually imposed on families during the ﬁrst 2–3
months, this may lead to the reduction in the quality of their
lives[30]. There are many factors causing treatment delay and
treatment failure including lack of compliance to the treatment
protocol, improper nutrition during treatment, wrong treatment
regimen, delayed treatment, problems in drug distribution, lack
of timely supervision and correct advice on the way of taking
drugs[27,31]. According to the mentioned points, the treatment
status in cured and completed treatment group in Babol City is
better than that has been reported in other studies.The rate of adverse effects of medicines in this study was 7.5%.
In study of Farazi et al., acute side effects and mild side effects
were observed in 17.6% and 82.4% of the patients, respectively[31].
A study of Ayatollahi and Khavandegaran in Shiraz City, Iran
reported that 29.5% of TB patients had mild and 5.2% had
acute drug adverse effects[32]. In a study conducted in Guilan
Province, Iran, almost 27.3% of TB patients reported more than
one drug side effect. Their side effects included liver failure
(48.2%), ocular complications (1.7%), intestinal complications
(82%) and dermal complications (5.3%)[33].
According to the results of this study, the most prevalent
symptoms in TB patients were cough, fever, sputum and weight
loss which are the most important signs for TB diagnosis. This
result is consistent with those of other studies in Iran in which
cough has been the most prevalent symptom in TB patients[34–36].
In study by Alavi et al. in Ahvaz City, Iran symptoms of cough,
fever and sweating at night in diabetic patients with TB were the
same as those in non-diabetic TB patients, but having sputum,
haemoptysis and dyspnoea were more prevalent among diabetic
TB patients in comparison with non-diabetic ones[37]. In a study
the more the age, the less the body mass. Also the response to
the tuberculin test was signiﬁcantly correlated with tuberculosis
clinical symptoms[38]. These symptoms may be emphasised in
training for the society. Health care worker should consider TB
as soon as they see these symptoms in a patient and do the
needed actions. In addition, these patients should be screened in
TB high risk group for early diagnosis.
About one fourth of patients in this study had reported the
history of contact with a TB patient. In a study, more than 50%
of patients had the history of contact with a TB patient in the
past time[20].
In this study, 14.5% of TB patients had diabetes mellitus. In
another study, 9.5% of TB patients were diabetic[20]. The
probability of TB treatment failure in patients having TB and
diabetes concurrently is higher[39]. The weakness of immune
system in patients with TB and diabetes is associated with
some factors such as reduction in the activity of alveolar
macrophages and decreased ability in producing
interleukin[40,41]. Therefore case ﬁnding among high risk groups
like diabetic patients is recommended.
A limitation of this study was the access to the medical re-
ports of patients only. In addition, due to the probability of under
reporting, the incidence rate is not calculated.
Based on the results of this study, it is needed to inform
people about main clinical symptoms of TB such as cough and
fever to diagnose and treat it as soon as possible and prevent the
spread of M. tuberculosis in the society. Of course having
effective treatment is very important. Active screening by health
care workers in TB high risk groups and symptomatic patients
and evaluation of barriers of implementing the preventive and
therapeutic programs in the society is emphasized.
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